Apple Analyst Sees $720 Ahead and 3 Investor Insights Making Rounds

Allergan Inc. (NYSE:AGN): Current Price: $103.19

The company’s price target has been increased to $108 from $95 at Deutsche Bank.

Capture

Should you buy or sell Apple’s stock ahead of earnings this month? Our 20-page proprietary analysis will help you save time and make money. Click here to get your SPECIAL REPORT now.

Facebook, Inc. (NASDAQ:FB): Current Price: $31.72

Piper Jaffray thinks that it is likely that Facebook will announce modest upgrades to the user and/or advertiser experience at tomorrow’s event, although there is a great deal of speculation of a major announcement. According to Piper, it would be a buyer of the stock on any weakness caused by  investor disappointment regarding the event. The firm also predicts that Facebook will report strong Q4 results, in-line with consensus expectations. Piper has decided to reiterate its Overweight rating and a $38 price target on the stock.

Capture

Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Get our fresh Feature Stock Pick now!

Sequenom Inc. (NASDAQ:SQNM): Current Price: $4.23

According to William Blair, there is value to investing in Sequenom shares after the pullback last week, and the firm reiterates its Outperform rating on the name. The firm is convinced that the stock is still able to work from these levels.

Capture

Should you buy or sell Apple’s stock ahead of earnings this month? Our 20-page proprietary analysis will help you save time and make money. Click here to get your SPECIAL REPORT now.

Apple Inc. (NASDAQ:AAPL): Current Price: $520.30

Bank of America Merrill Lynch stated that it already December’s estimates for Apple because of iPhone demand, and it would use weakness as a buying opportunity. Shares have a Buy rating and a $720 price target on the stock.

Capture

Don’t Miss: Are Apple Fears Overblown?